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Abstract 
A homozygous truncating mutation in nonreceptor tyrosine phosphatase 14 (PTPN14) has 
recently been associated with an extremely rare autosomal recessive syndrome of congenital 
posterior choanal atresia and childhood-onset lymphedema. PTPN14 has been shown to 
interact directly with the vascular endothelial growth factor receptor 3 (VEGFR3), a receptor 
tyrosine kinase essential for lymphangiogenesis.  Here we present an Iranian family with a 
single child affected by high-arched palate, congenital hypothyroidism, dysmorphic face, 
bilateral choanal atresia and infantile-onset lymphedema. Screening of the PTPN14 revealed 
a novel homozygous frameshift mutation in exon 4 predicted to result in premature truncation 
of the polypeptide product, which segregated with the disease phenotype. To our knowledge, 
this is the second family with ''choanal atresia and lymphedema syndrome'' to be reported 
worldwide.  In contrast to the first reported family that showed lymphedema in late 
childhood, the patient described here displays lymphedema in her lower limbs at early 
infancy associated with growth delay, mild facial swelling, congenital hypothyroidism and 
some minor developmental abnormalities. This report confirms the causality of PTPN14 loss-
of-function mutations and further expands the clinical phenotype of this rare genetic 
syndrome.  
Key words: PTPN14, Lymphedema, choanal atresia, mutation, 
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Abbreviations list 
PTPN14: protein tyrosine phosphatase, non-receptor type 14 
VEGFR3: vascular endothelial growth factor receptor 3 
FOXC2:  forkhead box C2 
CCBE1: collagen and calcium binding EGF domains 1 
 SOX18: SRY-box 18 
KIF11: kinesin family member 11  
 IKBKG: inhibitor of nuclear factor kappa B kinase subunit gamma 
 PTPN11: protein tyrosine phosphatase, non-receptor type 11 
GATA2: GATA binding protein 2 
 FAT4: FAT atypical cadherin 4  
NICU: neonatal intensive care unit 
CT-scan: computed tomography scan 
dbSNP: The Database of SNP 
GME: The Greater Middle East 
SNP: Single nucleotide polymorphic 
IUGR: Intrauterine growth restriction 
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1. Introduction 
An extremely rare autosomal recessive syndromic form of choanal atresia with 
childhood-onset lymphedema, high-arched palate and variable developmental abnormalities 
(OMIM#613611) in a consanguineous Yemenite kindred was first described in 1986 
(SHEIKH et al., 1986). Recently this condition was shown to be associated with a 
homozygous mutation in PTPN14 in nine affected members of this family (Au et al., 2010). 
PTPN14 encodes nonreceptor tyrosine phosphatase protein which has been suggested to be 
required for lymphangiogenesis (Au et al., 2010). The mutation defined was an intragenic 
homozygous 2,016-bp deletion encompassing intron 6 to intron 7 of the PTPN14 resulting in 
the loss of exon 7, frameshift (p.Ser194Argfs*19), and premature truncation (Au et al., 2010). 
All nine patients in the kindred displayed choanal atresia and by the age of 4 -6 years, six out 
of the nine had developed hard, non-pitting, lower limbs lymphedema (Har-El et al., 1991; 
Au et al., 2010). Around half of the patients presented a high-arched palate as well as other 
abnormalities including small nipples, pericardial effusions and pectus excavatum (Qazi et 
al., 1982; Har-El et al., 1991). To our knowledge, this is the only family reported worldwide 
with this clinical phenotype.  Patients with choanal atresia typically present with other 
congenital anomalies, the most common being coloboma, cardiac disease, mental and 
physical development and growth delay, genital hypoplasia and craniofacial abnormalities 
(e.g. CHARGE syndrome) (Burrow et al., 2009). Besides PTPN14, mutations in several other 
genes, including FOXC2, CCBE1, SOX18, KIF11, IKBKG, PTPN11, GATA2 and FAT4 have 
been identified to cause syndromes with lymphoedema as an associate feature (Fang et al., 
2000; Zonana et al., 2000; Tartaglia et al., 2001; Irrthum et al., 2003; Alders et al., 2009; 
Ostergaard et al., 2011; Ostergaard et al., 2012; Alders et al., 2014). The majority of their 
encoded proteins cluster within the signalling pathway of VEGFR3 (Mendola et al., 2013).  
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While a mouse model of PTPN14 deficiency did not display choanal atresia, around 
14 percent of the mutant animals showed forelimb and/or hindlimb swelling of the limb 
extremities or periorbital edema which started after 5 months of age (Au et al., 2010). These 
mice also displayed hyperplasia of lymphatic capillaries of the ears (Au et al., 2010). 
Mutations in PTPN14 have also been shown to be involved in tumorigenesis and have been 
associated with colorectal cancer, basal cell carcinoma and neuroblastoma (Laczmanska and 
Sasiadek, 2011; Schramm et al., 2015; Wang et al., 2015; Bonilla et al., 2016). Furthermore, 
it is proposed that PTPN14 may regulate angiogenesis and/or arteriovenous specification 
implicated as abnormal in pathology of hereditary haemorrhagic telangiectasia (Benzinou et 
al., 2012; Letteboer et al., 2015). Although suggestions have been made regarding the 
biological role of PTPN14 in the regulation of the lymphatic system in mouse, the 
physiologic relevance of the protein to choanal development as one of the two main features 
of this syndrome, as well as high-arched palate in humans, is still poorly understood.
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2. Material and Methods 
2.1. Patients Phenotype analysis  
This study, including clinical data collection and genomic analysis, was approved by 
the local institutional ethics committee of the Iran University of Medical Sciences, and all 
participants provided their written informed consent.  The medical records of the patient were 
reviewed and the patient was examined by the clinical team of the Shahid Akbar-Abadi 
Hospital. Detailed patient family history was collected and pedigree was drawn accordingly 
(Fig. 1). Blood samples from the proband and her parents were collected for genetic testing.  
 
Fig. 1: Pedigree of the proband IV:1 born to a first cousin parents III:1 and III:2. 
2.2. Genetic study genotype analysis 
Genomic DNA was extracted from each participant’s blood sample using the Qiagen 
Gentra Puregene DNA isolation kit (Valencia, CA). Mutation analysis was performed by 
PCR amplifying all exons and exon-intron boundaries of the PTPN14, using twenty-two pairs 
of primers. Primer sequences and screening conditions are available upon request. All the 
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resulting amplicons underwent bidirectional dideoxy sequencing using an Applied 
Biosystems 3730XL DNA Analyzer, and sequencing data was analysed using Geospiza’s 
FinchTV Software. 
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3. Results 
3.1. Clinical report 
Herein, we report on a two year old Iranian girl born at full-term with a history of 
intrauterine growth restriction (IUGR), weighing 1850 g, and measuring 39.5 cm in length 
and with a head circumference of 32 cm under 10
th
 centile. No history of medication (e.g. 
carbimozale), infectious diseases and drug/alcohol abuse was reported by mother during 
pregnancy. She was born by normal vaginal delivery to healthy first-cousin parents. She was 
admitted to the neonatal intensive care unit (NICU) of Shahid Akbar-Abadi Hospital 
(Tehran). She suffered from severe respiratory distress at birth and was immediately 
intubated, placed on mechanical ventilation and surfactant was administered. She was 
diagnosed with bilateral choanal atresia soon after birth and had seven corrective surgeries in 
the first five months after birth. She was dysmorphic with a “lymphedematous facial 
appearance” with hypertelorism, broad forehead, smooth philtrum, unilateral low set ear, 
high-arched palate and small nipples (Fig. 2).  
 
Fig. 2: Clinical photographs show mildly dysmorphic “Lymphedematous-looking face” of the 
patient and edema in her feet. 
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Subtle infraorbital swelling was observed below the right eye soon after birth. She 
displayed transient congenital hypothyroidism during the first year of her life, but at the age 
of one year this had resolved. On ultra-sound scan (at 18 month) the thyroid gland was in its 
normal location and its size appeared to be normal for her age. Systolic murmur (grade 3/6) 
was noted at the lower left sternal border and following cardiac assessment, a diagnosis of a 
small muscular ventricular septal defect with a good ejection fraction was made. At the age of 
two months she developed swelling of both feet up to her ankles.  
On examination at 22 months, the edema was firm, fibrotic and with pitting. This was 
unchanged at the latest follow-up (Fig. 2). The diagnosis of lymphedema was confirmed by 
lymphoscintigraphy. The radiotracer was injected in dorsal aspect of the feet. Neither the 
lymphatic vessels, nor the lymph nodes were seen, which means these vessels are not 
developed in the proband (aplasia or complete obstruction) (Fig. 3).  
 
Fig. 3: Picture of lymphoscintigraphy. 
The main lymphatic tracts of the lower limbs cannot be clearly visualised and there is 
no inguinal lymph node uptake at 60 minutes, representing a functional aplasia of the lower 
limb lymphatic system. There was no evidence of lymphedema in the other parts of her body. 
The parents did not have any history or signs of lymphedema.  
At follow-up at 24 months the growth parameters were as follow:  weight: 8.5 kg, 
height: 77c.m (below the 3
rd
 centile) and the head circumference was 46 cm (10
th
 centile). 
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The parent’s height was also below the 3rd centile (The father's height: 155 cm; his weight: 60 
kg and mother's height: 145 cm; her weight:52 kg).  
She had mild psychomotor developmental delay, which may be the result of the 
multiple surgeries, hospitalisation and prolonged NICU stay as she is currently catching-up 
with her developmental milestones. On CT-scan brain size and shape were normal. Her 
vision and hearing was normal. Furthermore, no other cutaneous abnormalities were detected. 
Although high-arched-palate and short stature were also present in the parents, there was no 
history of a similar condition in the family. All routine laboratory results were within normal 
range. Cytogenetic analysis showed a normal 46, XX female karyotype.  
3.2. Genetics analysis 
Direct sequencing of the 19 coding exons of PTPN14 identified a novel 2bp insertion 
mutation Chr1 (GRCh37): g.214588012_214588013insAA; NM_005401.4: c.401_402insTT; 
p.(Leu135Tyrfs*5) present in the homozygote state in the fourth exon of the gene (Fig. 4, 5) 
(blasted in NCBI).  
 
Fig. 4: The chromatograms show sequence of a section of exon 4. The top chromatogram 
revealed heterozygous insertion in parents and the bottom chromatogram is from sequencing 
of patient’s DNA with homozygous insertion mutation (indicated by dashed box). 
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Fig. 5: Fragment of wildtype sequence (top) of exon 4 aligned to mutant sequence (bottom). 
 
The mutation results in a frameshift which is predicted to cause polypeptide 
truncation and premature termination.  Both parents were found to be heterozygous carriers 
of the variant, and the variant was not found in dbSNP, EVS/ESP, 1000Genoame, ExAC, The 
Greater Middle East (GME) Variome Project as well as our in-house Exome sequencing 
database.  Apart from this likely deleterious variant six rare single nucleotide polymorphic 
(SNP) variants, all homozygous, were identified in other exons of the gene (Fig. 6). 
 
Fig. 6: Genomic organization of the PTPN14 and position of the mutation in exon 4 (red 
arrow) and other rare homozygous SNPs across the gene. 
4. Discussion 
Previously a report established that a null mutation in PTPN14 is likely to be 
responsible for the main clinical features of the choanal atresia and lymphedema syndrome 
(Au et al., 2010). These overlapping clinical features led to PTPN14 being considered as a 
candidate gene for the patient described here. Although exposure to some teratogenic factors 
such as carbimazole has been shown to be associated with occurrence of choanal atresia and 
other developmental abnormalities, no history of hyperthyroidism, thyrotoxicosis and use of 
carbimozale before and/or during pregnancy was noted in the mother of the patient 
(Greenberg et al., 1987; Papadimitriou et al., 2009). As with the previously described family, 
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the patient in this study presented with congenital choanal atresia and lower extremity 
lymphedema as the two cardinal clinical features (Table 1).
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+, present; -, absent; AAE, Age at examination; AOO, Age of onset; ABR,  auditory brainstem response; Bi, bilateral; CH, Congenital hypothyroidism; DD/ID, 
Developmental delay/intellectual disability; H: Height; ; HC: Head Circumference; IUGR,  Intrauterine growth restriction; NA, not applicable; NS, not stated; RDS, 
respiratory distress syndrome; Pt, patient; Uni, unilateral; VSD,  ventricular septal defect; W: Weight.  
*The Pt9 was an infant at the time of evaluation and he only had choanal  atresia.
Table 1: Comparison of clinical features of current patient with patients from Yemenite family with mutation in PTPN14. 
Clinical features Current Case Pt1 Pt2 Pt3 Pt4 Pt5 Pt6 Pt7 pt8 
gender Female male female female male male female female male 
Year & Age at 
examination 
(AAE) 
24 months 1976 
12 years 
1977 
11 years 
Stillbirth 1983 
6 years 
1989 Died at 5 months 1979 
9 years 
1985 
4 years 
Choanal atresia +/+ +/+ +/+ +/+ +/+ +/- +/+ +/+ +/+ 
Lymphedema 
(AOO) 
Bi Lower Extremities up to 
ankles 
2 Months 
Bi Lower extremities 
5 years 
Bi Lower 
extremities 
5 years 
NA Bi Lower 
extremities 
Up to ankles 
6 years 
Bi Lower 
extremities 
5 years 
NA Bi Lower 
extremities 
And thighs 
4 years 
Un Left Lower 
extremities 
4 years 
Highly-arched 
Palate 
+ + + NA + - NS + - 
DD/ID +/NA +/- -/- NA -/- -/- NA -/- -/- 
Growth 
parameters 
At 24 months 
W: 8.5 kg  <3
rd
  centile  
H: 77 cm   <3
rd
  centile  
HC: 46 cm 10
th
 centile  
At 11 months  
W: <3
rd
 centile  
H: 3
rd
 centile 
HC: 48 cm (75
th
 
centile) 
At 8 months 
W: 8 Kg 
H: NS 
HC: 46.5 (95
th
 
centile)  
NA NA NA NA NA NA 
Small Nipples + + - - - - - - - 
Dysmorphic 
features  
broad forehead, 
Hypertelorism, 
Lymphedematous-looking 
face, low nasal bridge,  uni 
low-set ear, smooth 
philtrum, Slight 
Micrognathia 
large head and 
ventricular dilation, 
slight hypertelorism, 
severe open-bite 
deformity, slight 
pectus excavatum  
Slight Micrognathia NA Open-bite 
deformity 
NS NS NS NS 
Other 
abnormalities 
IUGR, CH, VSD, Abnormal 
ABR, RDS 
Pericardial effusion Pericardial effusion 
RDS and cyanosis 
NS NS paraplegic 
Spina bifida 
Death due to 
Complications of 
measles 
Diffuse spotty 
discoloration of 
lower extremities 
Mild RDS, cyanosis 
NS 
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 While the age of onset for lymphedema in the proband is much earlier than all 
reported patients, the location of edema was only limited to her feet like patient 4 (Table 1). 
Additionally, the patient demonstrated other anomalies not previously described in this 
syndrome including congenital hypothyroidism, IUGR, delayed growth and a dysmorphic 
swollen-looking face. Other clinical features in the patient which overlap with the Yemenite 
kindred include high-arched palate, cardiac condition, small nipples and mild developmental 
delay. Comparable to the patient 1 from previous report who had only developmental delay 
not leading to intellectual disability later in childhood (12 years old), the patient in this study 
had mild neurodevelopmental delay but she is catching up with her milestones and has grown 
out of it.  
The patient was born small for gestational age and her growth was delayed. previous 
animal model study also showed a significant growth delay in mutant PTPN14 mice in 
comparison with wild type controls (Au et al., 2010). Nevertheless, growth was reported 
normal in most of Yemenite patients [Qazi et al., 1982, Har-El et al., 1991] Given the fact 
that both parents of the proband are also short, growth delay in the patient might be due to 
familial short stature and/or constitutional delay of growth.   
In the Yemenite kindred, the lymphedema was reported as juvenile onset, was limited 
to the lower limbs, and was not progressive since its onset (Table 1). PTPN14 deficient mice 
displayed swelling of the limbs or/and periorbital edema (Au et al., 2010). None of the 
Yemenite family members have been reported to display periorbital edema. Proband was 
born with a “puffy” appearance in face and mild right infraorbital swelling was noticed at 
birth. The lymphedematous looking face of proband can be secondary symptoms to her 
congenital hypothyroidism or perhaps related to periorbital lymphedema as reported in the 
mouse model. A pattern of congenital generalised edema / non-immune hydrops has been 
reported in association with congenital hypothyroidism, however the swelling disappear upon 
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resolution of the hypothyroid problem (Mizell et al., 2010). As the onset of the lower limb 
lymphedema in proband is after the hypothyroidism, we speculate it is less likely to be related 
to the patient’s transient hypothyroidism. In addition, according to the lymphoscintigraphy 
results there was no evidence of lymphatic drainage (Fig. 3) in proband suggesting lower 
limb lymphatic vessel obstruction. The lymphedema in proband has not progressed as far as 
in some of the Yemenite family members, but then she is still young. Therefore, we do not 
know if she has fully demonstrated the phenotype or if her lymphedema will become more 
severe or develop in other parts of the body as she becomes older.  
Due to extreme rarity of this syndrome and very few reported patients, the phenotypic 
spectrum of this syndrome is not fully appreciated and we cannot confidently say that the 
additional features manifesting in the current patients and previous cases are part of the 
syndrome. However, additional features shared between our patient and some of the previous 
cases are most likely associated with this syndrome (Table 1). Genetic and clinical 
characterisation of more patients with this syndrome would greatly increase our knowledge 
about this rare genetic disease.  
This report confirms truncating mutation of PTPN14 as likely responsible for choanal 
atresia and primary lymphedema and expands the mutational and clinical spectrum of gene 
mutation. 
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Legends 
Title and legends to Figures  
Fig. 1:  
Pedigree of the proband IV:1 born to a first cousin parents III:1 and III:2.  
Fig. 2: 
Clinical photographs show mildly dysmorphic “Lymphedematous-looking face” of the 
patient and edema in her feet.  
Fig. 3:  
Picture of lymphoscintigraphy 
Fig. 4: 
The chromatograms show sequence of a section of exon 4. The top chromatogram revealed 
heterozygous insertion in parents and the bottom chromatogram is from sequencing of 
patient’s DNA with homozygous insertion mutation (indicated by dashed box).  
Fig. 5: 
Fragment of wildtype sequence (top) of exon 4 aligned to mutant sequence (bottom).  
Fig. 6: 
 Genomic organization of the PTPN14 and position of the mutation in exon 4 (red arrow) and 
other rare homozygous SNPs across the gene. 
Table 1:  
Comparison of clinical features of the current patient with patients from Yemenite 
family1with a mutation in PTPN14. 
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Highlights 
Short collection of bullet points that convey the core findings of this article 
 
 The new homozygous truncating mutation in PTPN14 
 This report confirms the causality of PTPN14 mutations as pathogenic variant 
 This is the 2nd case with ''choanal atresia and lymphedema syndrome'' worldwide 
 This report expands the clinical phenotype of this rare genetic syndrome 
 In contrast to the 1st reported family, the patient displays lymphedema at early age 
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